• Keine Ergebnisse gefunden

ABRAHAM, N. G. & KAPPAS, A. 2005. Heme oxygenase and the cardiovascular-renal system.

Free radical biology & medicine, 39 (1), S. 1–25.

AGO, T. et al. 2004. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase.

Circulation, 109 (2), S. 227–233.

AHMED, N. 2005. Advanced glycation endproducts--role in pathology of diabetic complications.

Diabetes research and clinical practice, 67 (1), S. 3–21.

AHMED, M. U. et al. 1997. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. The Biochemical journal, 324 ( Pt 2), S. 565–570.

AHMED, M. U., THORPE, S. R. & BAYNES, J. W. 1986. Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. The Journal of biological chemistry, 261 (11), S. 4889–4894.

AKAGI, A. et al. 1999. Expression of type XVI collagen in human skin fibroblasts: enhanced expression in fibrotic skin diseases. The Journal of investigative dermatology, 113 (2), S.

246–250.

AKAGI, A. et al. 2002. Type XVI collagen is expressed in factor XIIIa+ monocyte-derived dermal dendrocytes and constitutes a potential substrate for factor XIIIa. The Journal of investigative dermatology, 118 (2), S. 267–274.

ALAM, J. & COOK, J. L. 2007. How many transcription factors does it take to turn on the heme oxygenase-1 gene? American journal of respiratory cell and molecular biology, 36 (2), S.

166–174.

ALBERTS, B. & JAENICKE, L. 2004. Molekularbiologie der Zelle. 4. Aufl. Weinheim: Wiley-VCH.

ALIKHANI, Z. et al. 2005. Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways. The Journal of biological chemistry, 280 (13), S. 12087–12095.

ALTMAN, D. A., FIVENSON, D. P. & LEE, M. W. 1992. Minocycline hyperpigmentation: model for in situ phagocytic activity of factor XIIIa positive dermal dendrocytes. Journal of cutaneous pathology, 19 (4), S. 340–345.

AMBASTA, R. K. et al. 2004. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. The Journal of biological chemistry, 279 (44), S. 45935–45941.

AOKI, H. et al. 2007. Gene expression profiling analysis of solar lentigo in relation to immunohistochemical characteristics. The British journal of dermatology, 156 (6), S. 1214–

1223.

ARCHAMBAULT, M., YAAR, M. & GILCHREST, B. A. 1995. Keratinocytes and fibroblasts in a human skin equivalent model enhance melanocyte survival and melanin synthesis after ultraviolet irradiation. The Journal of investigative dermatology, 104 (5), S. 859–867.

AVERY, N. C. & BAILEY, A. J. 2006. The effects of the Maillard reaction on the physical properties and cell interactions of collagen. Pathologie-biologie, 54 (7), S. 387–395.

BABA, H. et al. 2005. Human epidermal basal cell responses to ultraviolet-B differ according to their location in the undulating epidermis. Journal of dermatological science, 38 (1), S. 41–

46.

BABIOR, B. M. 1999. NADPH oxidase: an update. Blood, 93 (5), S. 1464–1476.

BABIOR, B. M., LAMBETH, J. D. & NAUSEEF, W. 2002. The neutrophil NADPH oxidase.

Archives of biochemistry and biophysics, 397 (2), S. 342–344.

BAILEY, A. J. et al. 1999. Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcified tissue international, 65 (3), S. 203–210.

BARNI, S. et al. 2002. Mechanisms of changes to the liver pigmentary component during the annual cycle (activity and hibernation) of Rana esculenta L. Journal of anatomy, 200 (Pt 2), S. 185–194.

BARRY, E. L. & MOSHER, D. F. 1989. Factor XIIIa-mediated cross-linking of fibronectin in fibroblast cell layers. Cross-linking of cellular and plasma fibronectin and of amino-terminal fibronectin fragments. The Journal of biological chemistry, 264 (7), S. 4179–4185.

BAYNES, J. W. & THORPE, S. R. 1999. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes, 48 (1), S. 1–9.

BEDARD, K. & KRAUSE, K. H. 2007. The NOX family of ROS-generating NADPH oxidases:

physiology and pathophysiology. Physiological reviews, 87 (1), S. 245–313.

BENNETT, D. C. & LAMOREUX, M. L. 2003. The color loci of mice--a genetic century. Pigment cell research, 16 (4), S. 333–344.

BER, R. S. & BHAWAN, J. 1996. Lentigo. International journal of dermatology, 35 (4), S. 229–

239.

BERSON, J. F. et al. 2001. Pmel17 initiates premelanosome morphogenesis within multivesicular bodies. Molecular biology of the cell, 12 (11), S. 3451–3464.

BICKERS, D. R. & ATHAR, M. 2006. Oxidative stress in the pathogenesis of skin disease. The Journal of investigative dermatology, 126 (12), S. 2565–2575.

BIERHAUS, A. et al. 1998. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovascular research, 37 (3), S. 586–600.

BIZOT-FOULON, V. et al. 1995. Uncoordinate expressions of type I and III collagens, collagenase and tissue inhibitor of matrix metalloproteinase 1 along in vitro proliferative life span of human skin fibroblasts. Regulation by all-trans retinoic acid. Cell biology international, 19 (2), S. 129–135.

BODE, W. & MASKOS, K. 2003. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases. Biological chemistry, 384 (6), S. 863–872.

BOISSY, R. E. 2003. Melanosome transfer to and translocation in the keratinocyte.

Experimental dermatology, 12 Suppl 2, S. 5–12.

BOROVANSKY, J. & ELLEDER, M. 2003. Melanosome degradation: fact or fiction. Pigment cell research, 16 (3), S. 280–286.

BOROVANSKY, J. et al. 1999. Attempts to induce melanosome degradation in vivo. Folia biologica, 45 (2), S. 47–52.

BOXMAN, I. et al. 1993. Modulation of IL-6 production and IL-1 activity by keratinocyte-fibroblast interaction. The Journal of investigative dermatology, 101 (3), S. 316–324.

BRAR, S. S. et al. 2002. An NAD(P)H oxidase regulates growth and transcription in melanoma cells. American journal of physiology, 282 (6), S. C1212-24.

BRAUN-FALCO, O. & SCHOEFINIUS, H. H. 1971. Lentigo senilis. Review and studies. Der Hautarzt, 22 (7), S. 277–283.

BREUHAHN, K. et al. 2000. Epidermal overexpression of granulocyte-macrophage colony-stimulating factor induces both keratinocyte proliferation and apoptosis. Cell growth &

differentiation, 11 (2), S. 111–121.

BRIGGAMAN, R. A. & WHEELER, C. rE.J. 1975. The epidermal-dermal junction. The Journal of investigative dermatology, 65 (1), S. 71–84.

BRUNK, U. T. & TERMAN, A. 2002. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free radical biology & medicine, 33 (5), S. 611–619.

BUNN, H. F. et al. 1975. Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c. Biochemical and biophysical research communications, 67 (1), S. 103–109.

BYERS, H. R. et al. 2003. Role of cytoplasmic dynein in perinuclear aggregation of phagocytosed melanosomes and supranuclear melanin cap formation in human keratinocytes. The Journal of investigative dermatology, 121 (4), S. 813–820.

CAMARA, N. O. & SOARES, M. P. 2005. Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction. Free radical biology & medicine, 38 (4), S. 426–435.

CARIO-ANDRE, M. et al. 2004. Perilesional vs. lesional skin changes in senile lentigo. Journal of cutaneous pathology, 31 (6), S. 441–447.

CAWLEY, E. P. & CURTIS, A. C. 1950. Lentigo senilis. A, 62 (5), S. 635–641.

CERAMI, A. 1985. Hypothesis. Glucose as a mediator of aging. Journal of the American Geriatrics Society, 33 (9), S. 626–634.

CERIO, R. et al. 1989. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. The British journal of dermatology, 121 (4), S. 421–431.

CHANG, H. Y. et al. 2002. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proceedings of the National Academy of Sciences of the United States of America, 99 (20), S. 12877–12882.

CHIARELLI, F. et al. 1999. Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications. The Journal of pediatrics, 134 (4), S. 486–491.

CHOMCZYNSKI, P. & SACCHI, N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical biochemistry, 162 (1), S.

156–159.

CLAUSEN, O. P. & POTTEN, C. S. 1990. Heterogeneity of keratinocytes in the epidermal basal cell layer. Journal of cutaneous pathology, 17 (3), S. 129–143.

COSTIN, G. E. & HEARING, V. J. 2007. Human skin pigmentation: melanocytes modulate skin color in response to stress. The FASEB journal, 21 (4), S. 976–994.

COTSARELIS, G. et al. 1999. Epithelial stem cells in the skin: definition, markers, localization and functions. Experimental dermatology, 8 (1), S. 80–88.

DEAN, N. R. et al. 2002. Immunohistochemical labeling of normal melanocytes. Applied immunohistochemistry & molecular morphology, 10 (3), S. 199–204.

DEGROOT, J. 2004. The AGE of the matrix: chemistry, consequence and cure. Current opinion in pharmacology, 4 (3), S. 301–305.

DEGUCHI, M. et al. 2002. Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease. Archives of dermatological research, 294 (7), S. 297–302.

DESOUKI, M. M. et al. 2005. Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer biology & therapy, 4 (12), S. 1367–

1373.

DEUTHER-CONRAD, W. et al. 2001. Differences in the modulating potential of advanced glycation end product (AGE) peptides versus AGE proteins. Kidney international, 78, S. S63-6.

DROGE, W. 2002. Free radicals in the physiological control of cell function. Physiological reviews, 82 (1), S. 47–95.

DROSTE, M. S.; 2007. Determining Factors of Skin Colouration : A Light and Electron

Microscopic Study of the Distribution of Melanin and Its Degradation in the Human Epidermis;

http://www.sub.uni-hamburg.de/opus/volltexte/2007/3276/

DYER, D. G. et al. 1991. Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. The Journal of biological chemistry, 266 (18), S. 11654–11660.

DYER, D. G. et al. 1993. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. The Journal of clinical investigation, 91 (6), S. 2463–2469.

KUEPER, T. et al. 2007. Vimentin is the specific target in skin glycation. Structural prerequisites, functional consequences, and role in skin aging. The Journal of biological chemistry, 282 (32), S. 23427–23436.

ECKES, B. et al. 1999. Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis. Springer seminars in immunopathology, 21 (4), S. 415–429.

EL-DOMYATI, M. et al. 2002. Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Experimental dermatology, 11 (5), S.

398–405.

EL-LABBAN, N. G. 1988. Melanin-forming Schwann cells in some oral mucosal lesions.

Histopathology, 12 (3), S. 301–306.

ESKELINEN, E. L. 2005. Maturation of autophagic vacuoles in Mammalian cells. Autophagy, 1 (1), S. 1–10.

ESPOSITO, F. et al. 2004. Redox control of signal transduction, gene expression and cellular senescence. Neurochemical research, 29 (3), S. 617–628.

FATTMAN, C. L., SCHAEFER, L. M. & OURY, T. D. 2003. Extracellular superoxide dismutase in biology and medicine. Free radical biology & medicine, 35 (3), S. 236–256.

FINKEL, T. & HOLBROOK, N. J. 2000. Oxidants, oxidative stress and the biology of ageing.

Nature, 408 (6809), S. 239–247.

FISHER, G. J. et al. 2002. Mechanisms of photoaging and chronological skin aging. Archives of dermatology, 138 (11), S. 1462–1470.

FITZPATRICK, T. B. 1988. The validity and practicality of sun-reactive skin types I through VI.

Archives of dermatology, 124 (6), S. 869–871.

FITZPATRICK, T. B. & BREATHNACH, A. S. 1963. THE EPIDERMAL MELANIN UNIT SYSTEM. Dermatologische Wochenschrift, 147, S. 481–489.

FREEDBERG, I. M. & FITZPATRICK, T. B. 1999. Fitzpatricks Dermatology in General Medicine:

McGraw Hill (Tx) Customer Service.

FREI, B. 1994. Reactive oxygen species and antioxidant vitamins: mechanisms of action. The American journal of medicine, 97 (3A), S. 5S-13S; discussion 22S-28S.

FREINKEL, R. K. 2001. The biology of the skin. New York: Parthenon.

FRITSCH, P. 1998. Dermatologie und Venerologie. Lehrbuch und Atlas ; mit 295 Tabellen.

Berlin: Springer. (Springer-Lehrbuch).

FUCHS, E. & RAGHAVAN, S. 2002. Getting under the skin of epidermal morphogenesis. Nature reviews, 3 (3), S. 199–209.

FULLEN, D. R. & HEADINGTON, J. T. 1998. Factor XIIIa-positive dermal dendritic cells and HLA-DR expression in radial versus vertical growth-phase melanomas. Journal of cutaneous pathology, 25 (10), S. 553–558.

FURBER, J. D. 2006. Extracellular glycation crosslinks: prospects for removal. Rejuvenation research, 9 (2), S. 274–278.

GARCIA, R. I. & SZABO, G. 1979. Melanosomes in dermal Schwann cells of human and rodent skin. Archives of dermatological research, 264 (1), S. 83–87.

GASIC-MILENKOVIC, J. et al. 2001. Protein "AGEing"--cytotoxicity of a glycated protein increases with its degree of AGE-modification. Zeitschrift fur Gerontologie und Geriatrie, 34 (6), S. 457–460.

GEISZT, M. et al. 2000. Identification of renox, an NAD(P)H oxidase in kidney. Proceedings of the National Academy of Sciences of the United States of America, 97 (14), S. 8010–8014.

GELSE, K., POSCHL, E. & AIGNER, T. 2003. Collagens--structure, function, and biosynthesis.

Advanced drug delivery reviews, 55 (12), S. 1531–1546.

GEROLDI, D., FALCONE, C. & EMANUELE, E. 2006. Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target. Current medicinal chemistry, 13 (17), S. 1971–1978.

GHAZIZADEH, S. & TAICHMAN, L. B. 2001. Multiple classes of stem cells in cutaneous epithelium: a lineage analysis of adult mouse skin. The EMBO journal, 20 (6), S. 1215–1222.

GIBBS, S. et al. 2000. Melanosome capping of keratinocytes in pigmented reconstructed epidermis--effect of ultraviolet radiation and 3-isobutyl-1-methyl-xanthine on melanogenesis.

Pigment cell research, 13 (6), S. 458–466.

GIBRAN, N. S., HEIMBACH, D. M. & HOLBROOK, K. A. 1995. Immunolocalization of FXIIIa+

dendritic cells in human burn wounds. The Journal of surgical research, 59 (3), S. 378–386.

GIBRAN, N. S., NICKOLOFF, B. J. & HOLBROOK, K. A. 1996. Ontogeny and characterization of factor XIIIa+ cells in developing human skin. Anatomy and embryology, 193 (1), S. 35–41.

GILCHREST, B. A., BLOG, F. B. & SZABO, G. 1979. Effects of aging and chronic sun exposure on melanocytes in human skin. The Journal of investigative dermatology, 73 (2), S. 141–143.

GILCHREST, B. A. et al. 1983. Autocrine and paracrine growth stimulation of cells derived from human skin. Journal of cellular physiology, 117 (2), S. 235–240.

GONTIER, E. et al. 2003. The 'Abtropfung phenomenon' revisited: Dermal nevus cells from congenital nevi cannot activate matrix metalloproteinase 2 (MMP-2). Pigment cell research, 16 (4), S. 366–373.

GONZALEZ-RAMOS, A., COOPER, K. D. & HAMMERBERG, C. 1996. Identification of a human dermal macrophage population responsible for constitutive restraint of primary dermal fibroblast proliferation. The Journal of investigative dermatology, 106 (2), S. 305–311.

GRANDHEE, S. K. & MONNIER, V. M. 1991. Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. The Journal of biological chemistry, 266 (18), S. 11649–11653.

GRIMES, P. E., YAMADA, N. & BHAWAN, J. 2005. Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma. The American Journal of dermatopathology, 27 (2), S. 96–101.

GRINNELL, F. 1984. Fibronectin and wound healing. Journal of cellular biochemistry, 26 (2), S.

107–116.

HADDAD, M. M., XU, W. & MEDRANO, E. E. 1998. Aging in epidermal melanocytes: cell cycle genes and melanins. The journal of investigative dermatology, 3 (1), S. 36–40.

HALLIWELL, B. & GUTTERIDGE, J. M. 1984b. Free radicals, lipid peroxidation, and cell damage. Lancet, 2 (8411), S. 1095.

HALLIWELL, B. & GUTTERIDGE, J. M. 1984a. Oxygen toxicity, oxygen radicals, transition metals and disease. The Biochemical journal, 219 (1), S. 1–14.

HALLIWELL, B. & GUTTERIDGE, J. M. 1990. Role of free radicals and catalytic metal ions in human disease: an overview. Methods in enzymology, 186, S. 1–85.

HAM, A. W. & CORMACK, D. H. 1987. Ham's histology. 9. ed., 1. [Dr.]. Philadelphia: Lippincott.

HANINEC, P. & VACHTENHEIM, J. 1988. Tyrosinase protein is expressed also in some neural crest derived cells which are not melanocytes. Pigment cell research, 1 (5), S. 340–343.

HARATAKE, A. et al. 1997. UVB-induced alterations in permeability barrier function: roles for epidermal hyperproliferation and thymocyte-mediated response. The Journal of investigative dermatology, 108 (5), S. 769–775.

HARMAN, D. 1956. Aging: a theory based on free radical and radiation chemistry. Journal of gerontology, 11 (3), S. 298–300.

HARRISON, D. et al. 2003. Role of oxidative stress in atherosclerosis. The American journal of cardiology, 91 (3A), S. 7A-11A.

HEADINGTON, J. T. 1986. The dermal dendrocyte. Advances in dermatology, 1, S. 159–171.

HEDLEY, S. J. et al. 2002. Fibroblasts play a regulatory role in the control of pigmentation in reconstructed human skin from skin types I and II. Pigment cell research, 15 (1), S. 49–56.

HILENSKI, L. L. et al. 2004. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arteriosclerosis, thrombosis, and vascular biology, 24 (4), S. 677–683.

HOASHI, T. 2005. MART-1 Is Required for the Function of the Melanosomal Matrix Protein PMEL17GP100 and the Maturation of Melanosomes. The journal of biological chemistry, S.

Vol. 280, No. 14 (2005),14006-14016.

HODGSON, C. 1963. Senile lentigo. Archives of dermatology, 87, S. 197–207.

HOLZLE, E. 1992a. Pigmented lesions as a sign of photodamage. The British journal of dermatology, 127 Suppl 41, S. 48–50.

HORI, R. et al. 2002. Gene transfection of H25A mutant heme oxygenase-1 protects cells against hydroperoxide-induced cytotoxicity. The Journal of biological chemistry, 277 (12), S.

10712–10718.

HORIKOSHI, T., JIMBOW, K. & SUGIYAMA, S. 1982. Comparison of macromelanosomes and autophagic giant melanosome complexes in nevocellular nevi, lentigo simplex and malignant melanoma. Journal of cutaneous pathology, 9 (5), S. 329–339.

HOUBEN, E., PAEPE, K. de & ROGIERS, V. 2007. A keratinocyte's course of life. Skin pharmacology and physiology, 20 (3), S. 122–132.

HOWARD, E. W. et al. 1996. Cellular contraction of collagen lattices is inhibited by nonenzymatic glycation. Experimental cell research, 228 (1), S. 132–137.

HUI, Y. Y. et al. 2001. Effect of advanced glycation end products on oxidative stress in endothelial cells in culture: a warning on the use of cells studied in serum-free media.

Diabetologia, 44 (10), S. 1310–1317.

HUMPHRIES, M. J. 2000. Integrin cell adhesion receptors and the concept of agonism. Trends in pharmacological sciences, 21 (1), S. 29–32.

IKEDA, K. et al. 1996. N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry, 35 (24), S. 8075–8083.

IMMENSCHUH, S. & RAMADORI, G. 2000. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochemical pharmacology, 60 (8), S. 1121–1128.

IMOKAWA, G. 2004. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment cell research, 17 (2), S. 96–110.

IMOKAWA, G., MIYAGISHI, M. & YADA, Y. 1995. Endothelin-1 as a new melanogen:

coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. The Journal of investigative dermatology, 105 (1), S. 32–37.

JEANMAIRE, C., DANOUX, L. & PAULY, G. 2001. Glycation during human dermal intrinsic and actinic ageing: an in vivo and in vitro model study. The British journal of dermatology, 145 (1), S. 10–18.

JENSEN, U. B., LOWELL, S. & WATT, F. M. 1999. The spatial relationship between stem cells and their progeny in the basal layer of human epidermis: a new view based on whole-mount labelling and lineage analysis. Development, 126 (11), S. 2409–2418.

JIMBOW, K. 1985. Elucidation of melanogenesis and its application to clinical diagnosis and treatment. Nippon Hifuka Gakkai zasshi, 95 (12 Suppl), S. 1253–1255.

JIMBOW, K. 1995. Current update and trends in melanin pigmentation and melanin biology. The Keio journal of medicine, 44 (1), S. 9–18.

JIMBOW, K. & HORIKOSHI, T. 1982. The nature and significance of macromelanosomes in pigmented skin lesions: their morphological characteristics, specificity for their occurrence, and possible mechanisms for their formation. The American Journal of dermatopathology, 4 (5), S. 413–420.

JIMBOW, K. et al. 1976. Some aspects of melanin biology: 1950-1975. The Journal of investigative dermatology, 67 (1), S. 72–89.

JONES, P. H., HARPER, S. & WATT, F. M. 1995. Stem cell patterning and fate in human epidermis. Cell, 80 (1), S. 83–93.

JONES, P. H. & WATT, F. M. 1993. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell, 73 (4), S. 713–724.

KADONO, S. et al. 2001. The role of the epidermal endothelin cascade in the hyperpigmentation mechanism of lentigo senilis. The Journal of investigative dermatology, 116 (4), S. 571–577.

KAHN, H. J., BAUMAL, R. & MARKS, A. 1984. The value of immunohistochemical studies using antibody to S100 protein in dermatopathology. International journal of dermatology, 23 (1), S.

38–44.

KAMIMURA, J. et al. 1997. Primary mouse keratinocyte cultures contain hair follicle progenitor cells with multiple differentiation potential. The Journal of investigative dermatology, 109 (4), S. 534–540.

KASPER, M. et al. 1999. Experimental induction of AGEs in fetal L132 lung cells changes the level of intracellular cathepsin D. Biochemical and biophysical research communications, 261 (1), S. 175–182.

KAWAHARA, T. et al. 2005. Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation. The Journal of biological chemistry, 280 (36), S. 31859–31869.

KENT, M. J., LIGHT, N. D. & BAILEY, A. J. 1985. Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation in vitro. The Biochemical journal, 225 (3), S. 745–752.

KIM, Y. S. & DORE, S. 2005. Catalytically inactive heme oxygenase-2 mutant is cytoprotective.

Free radical biology & medicine, 39 (4), S. 558–564.

KIRFEL, G. et al. 2004. Cell migration: mechanisms of rear detachment and the formation of migration tracks. European journal of cell biology, 83 (11-12), S. 717–724.

KLIGMAN, L. H. & KLIGMAN, A. M. 1986. The nature of photoaging: its prevention and repair.

Photo-dermatology, 3 (4), S. 215–227.

KNIGHT, C. G. et al. 2000. The collagen-binding A-domains of integrins alpha(1)beta(1) and alpha(2)beta(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. The Journal of biological chemistry, 275 (1), S. 35–40.

KONDO, S. 2000. The roles of cytokines in photoaging. Journal of dermatological science, 23 Suppl 1, S. S30-6.

KOSTER, M. I. & ROOP, D. R. 2004. Genetic pathways required for epidermal morphogenesis.

European journal of cell biology, 83 (11-12), S. 625–629.

KRAUSE, K. H. 2004. Tissue distribution and putative physiological function of NOX family NADPH oxidases. Japanese journal of infectious diseases, 57 (5), S. S28-9.

KURODA, J. et al. 2005. The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes to cells, 10 (12), S. 1139–1151.

LAKI, K. 1972. The biological role of the clot stabilizing enzymes. Transglutaminase and factor XIII ; result of a Conference Entitled the Biological Role of the Clot Stabilizing Enzymes:

Transglutaminase and Factor XIII, held by the New York Academy of Sciences on November 18 and 19, 1971. New York N.Y. (Annals of the New York Academy of Sciences; 202).

LAMBETH, J. D. 2004. NOX enzymes and the biology of reactive oxygen. Nature reviews, 4 (3), S. 181–189.

LANONE, S. et al. 2005. Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase:

implications for protection against endotoxic shock in rats. The FASEB journal, 19 (13), S.

1890–1892.

LAPORTE, M. & HEENEN, M. 1994. The heterogeneity of the germinative compartment in human epidermis and its implications in pathogenesis. Dermatology, 189 (4), S. 340–343.

LAPPIN, M. B., KIMBER, I. & NORVAL, M. 1996. The role of dendritic cells in cutaneous immunity. Archives of dermatological research, 288 (3), S. 109–121.

LARREGINA, A. T. & FALO, L. rD.J. 2005. Changing paradigms in cutaneous immunology:

adapting with dendritic cells. The Journal of investigative dermatology, 124 (1), S. 1–12.

LAVKER, R. M. 1979. Structural alterations in exposed and unexposed aged skin. The Journal of investigative dermatology, 73 (1), S. 59–66.

LAVKER, R. M. & KLIGMAN, A. M. 1988. Chronic heliodermatitis: a morphologic evaluation of chronic actinic dermal damage with emphasis on the role of mast cells. The Journal of investigative dermatology, 90 (3), S. 325–330.

LAVKER, R. M. & SUN, T. T. 1982. Heterogeneity in epidermal basal keratinocytes:

morphological and functional correlations. Science, 215 (4537), S. 1239–1241.

LAVKER, R. M. & SUN, T. T. 1983. Epidermal stem cells. The Journal of investigative dermatology, 81 (1 Suppl), S. 121s-7s.

LAVKER, R. M., ZHENG, P. S. & DONG, G. 1987. Aged skin: a study by light, transmission electron, and scanning electron microscopy. The Journal of investigative dermatology, 88 (3 Suppl), S. 44s-51s.

LEE, J. H. et al. 2002. Acute effects of UVB radiation on the proliferation and differentiation of keratinocytes. Photodermatology, photoimmunology & photomedicine, 18 (5), S. 253–261.

LEE, A. T. & CERAMI, A. 1992. Role of glycation in aging. Annals of the New York Academy of Sciences, 663, S. 63–70.

LEE, D. Y. & CHO, K. H. 2005. The effects of epidermal keratinocytes and dermal fibroblasts on the formation of cutaneous basement membrane in three-dimensional culture systems.

Archives of dermatological research, 296 (7), S. 296–302.

LÖFFLER, G. & PETRIDES, P. E. 1998. Biochemie und Pathobiochemie. Mit 233 Tabellen. 6., korrigierte Aufl. Berlin: Springer. (Springer-Lehrbuch).

LOSKE, C. et al. 1998. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. Journal of neural transmission, 105 (8-9), S. 1005–1015.

MACK, J. A., ANAND, S. & MAYTIN, E. V. 2005. Proliferation and cornification during development of the mammalian epidermis. Birth defects research, 75 (4), S. 314–329.

MACKENZIE, I. C. 1997. Retroviral transduction of murine epidermal stem cells demonstrates clonal units of epidermal structure. The Journal of investigative dermatology, 109 (3), S. 377–

383.

MADISON, K. C. 2003. Barrier function of the skin: "la raison d'etre" of the epidermis. The Journal of investigative dermatology, 121 (2), S. 231–241.

MAKITA, Z. et al. 1991. Advanced glycosylation end products in patients with diabetic nephropathy. The New England journal of medicine, 325 (12), S. 836–842.

MARCHESE, C. et al. 2001. Fibroblast growth factor 10 induces proliferation and differentiation of human primary cultured keratinocytes. The Journal of investigative dermatology, 116 (4), S. 623–628.

MARIONNET, C. et al. 2006. Interactions between fibroblasts and keratinocytes in morphogenesis of dermal epidermal junction in a model of reconstructed skin. The Journal of investigative dermatology, 126 (5), S. 971–979.

MARKLUND, S. L. 1990. Expression of extracellular superoxide dismutase by human cell lines.

The Biochemical journal, 266 (1), S. 213–219.

MARTYN, K. D. et al. 2006. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cellular signalling, 18 (1), S. 69–82.

MAUSNBACH, A. B., 1969. Lysosomes in biology and pathology 1, S. 115–125.

MASAKI, H., OKANO, Y. & SAKURAI, H. 1999. Generation of active oxygen species from advanced glycation end-products (AGEs) during ultraviolet light A (UVA) irradiation and a possible mechanism for cell damaging. Biochimica et biophysica acta, 1428 (1), S. 45–56.

MASU, S. & SEIJI, M. 1983. Pigmentary incontinence in fixed drug eruptions. Histologic and electron microscopic findings. Journal of the American Academy of Dermatology, 8 (4), S.

525–532.

MATSUMOTO, H. et al. 2006. Carbon monoxide and bilirubin from heme oxygenase-1 suppresses reactive oxygen species generation and plasminogen activator inhibitor-1 induction. Molecular and cellular biochemistry, 291 (1-2), S. 21–28.

MAYER, C. et al. 2004. Release of cell fragments by invading melanoma cells. European journal of cell biology, 83 (11-12), S. 709–715.

MCCARTHY, A. D. et al. 2004. Advanced glycation endproducts interefere with integrin-mediated osteoblastic attachment to a type-I collagen matrix. The international journal of biochemistry & cell biology, 36 (5), S. 840–848.

MCINTYRE, M., BOHR, D. F. & DOMINICZAK, A. F. 1999. Endothelial function in hypertension:

the role of superoxide anion. Hypertension, 34 (4 Pt 1), S. 539–545.

MECHAM, B. H. et al. 2004. Increased measurement accuracy for sequence-verified microarray probes. Physiological genomics, 18 (3), S. 308–315.

MEHREGAN, A. H. 1975. Lentigo senilis and its evolutions. The Journal of investigative dermatology, 65 (5), S. 429–433.

MIKI, H. C. et al. 2002. Conversion of Amadori products of the Maillard reaction to N(epsilon)-(carboxymethyl)lysine by short-term heating: possible detection of artifacts by immunohistochemistry. Laboratory investigation, 82 (6), S. 795–808.

MISHIMA, Y. 1966. Cellular and subcellular differentiation of melanin phagocytosis and synthesis by lysosomal and melanosomal activity. The Journal of investigative dermatology, 46 (1), S. 70–75.

MIYATA, T. et al. 1996. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. The Journal of clinical investigation, 98 (5), S. 1088–1094.

MIYATA, S. et al. 1997. Accumulation of pyrraline-modified albumin in phagocytes due to reduced degradation by lysosomal enzymes. The Journal of biological chemistry, 272 (7), S.

4037–4042.

MIYAZAWA, N. et al. 1998. Immunological detection of fructated proteins in vitro and in vivo.

The Biochemical journal, 336 ( Pt 1), S. 101–107.

MIZUTARI, K. et al. 1997. Photo-enhanced modification of human skin elastin in actinic elastosis by N(epsilon)-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction. The Journal of investigative dermatology, 108 (5), S. 797–802.

MONNIER, V. M. & SELL, D. R. 2006. Prevention and repair of protein damage by the Maillard reaction in vivo. Rejuvenation research, 9 (2), S. 264–273.

MONTAGNA, W. & CARLISLE, K. 1990. Structural changes in ageing skin. The British journal of dermatology, 122 Suppl 35, S. 61–70.

MONTAGNA, W., HU, F. & CARLISLE, K. 1980. A reinvestigation of solar lentigines. Archives of dermatology, 116 (10), S. 1151–1154.

MONTEIRO, M. R. et al. 2000. Cytological alterations in dermal dendrocytes in vitro: evidence for transformation to a non-dendritic phenotype. The British journal of dermatology, 143 (1), S. 84–90.

MONTEIRO, M. R. et al. 1999. Von Willebrand factor receptor GPIb alpha is expressed by human factor XIIIa-positive dermal dendrocytes and is upregulated by mast cell degranulation. The Journal of investigative dermatology, 113 (2), S. 272–276.

MOULIN, V. 1995. Growth factors in skin wound healing. European journal of cell biology, 68 (1), S. 1–7.

MUNCH, G. et al. 1997. Advanced glycation endproducts in ageing and Alzheimer's disease.

Brain research, 23 (1-2), S. 134–143.

MYLLYHARJU, J. & KIVIRIKKO, K. I. 2001. Collagens and collagen-related diseases. Annals of medicine, 33 (1), S. 7–21.